Outcome in Patients with Non‐Hodgkin Lymphoma and With or Without Human Immunodeficiency Virus Infection

Open Access
Publisher Website
Google Scholar
Abstract
We compared the clinical characteristics and outcomes of 100 patients with human immunodeficiency virus (HIV)-associated non-Hodgkin lymphoma (NHL; HIV-NHL) treated in the highly active antiretroviral therapy era with those of 82 HIV-negative patients with aggressive NHL. The 3-year overall survival (OS) was 37% among patients with HIV-NHL and 74% among HIV-negative patients with NHL (P < .0001). However, the response-adjusted OS was similar in the 2 groups (hazard ratio, 1.4 for HIV-infected patients vs. 1 for HIV-negative patients; P = .24). Therefore, the achievement of complete remission should be the main goal in the treatment of patients with HIV-NHL.